RIPTAC™ Therapeutics: A Modality to Take Hold of Human Diseases – Pushing the Frontiers of Induced Proximity Drugs
Time: 2:30 pm
day: Day One
Details:
- How to harness RIPTAC™ therapeutics as a novel drug modality that employs a hold and kill mechanism to selectively target tumors and induce cancer cell death
- How to optimize the design of bifunctional small molecules to drive the formation of protein-protein interactions for enhanced therapeutic efficacy
- How to expand beyond traditional precision oncology by leveraging RIPTAC™ therapeutics to overcome resistance mechanisms and extend treatment options for cancer patients